Our work on the diversity of aquaculture pathogens has led to the development of a new method for detecting and identifying microorganisms responsible for fish farm mortalities. This method, based on a combination of artificial intelligence and high-resolution DNA melting, simultaneously enables sensitive, rapid and low-cost diagnosis of many pathogens. A proof of concept carried out on 19 species of mycobacteria led to an industrial maturation by SATT-AxLR. This innovation has been patented, and an exclusive license agreement has been signed with Innovative Diagnostics for its use in animal health. To apply this innovation to the diagnosis of human infectious diseases, AFYIA Diagnostics was created in 2023. With 15 employees, this start-up aims to make diagnostics accessible to all.
